An expert emphasizes that genomic profiling—including both germline and somatic testing—is now essential in metastatic ...

Tailoring medicines to an individual’s genetic profile is now possible. One critical aspect is genetic testing that reduces ...

A combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid ...

We describe findings from genomic profiling of tumors among infantile pediatric patients studied within a translational research protocol established at our pediatric tertiary care center.

This study evaluates the utility of comprehensive genomic profiling (CGP) and genome-matched therapies for AYA cancer patients, considering age-specific variations using a nationwide database. Methods ...

Myelodysplastic syndromes (MDS) are a group of disorders that typically arise in adulthood, especially after the age of 70, ...

Think of genetic testing in sports and the likelihood is your mind will turn to recent high-profile stories around gender ...

A study reveals significant genomic differences in metastatic prostate cancer among veterans, highlighting the need for ...

Nucleus Genomics has announced the world's first genetic optimization software that can test for up to 900 conditions in ...

FORT MYERS, Fla., May 28, 2025--NeoGenomics will debut its PanTracer Family and unveil the Paletrra platform at ASCO 2025, advancing precision oncology diagnostics.